Linda Burkly, EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. (EDIT), sold 23,772 shares at $5.42 ($129K) on 2024-07-25, disclosed to the SEC on 2024-07-26.
Scheduled sale ($129k) by EVP, CHIEF SCIENTIFIC OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.42 | 11,886 | $64K | 50.0% |
| 2 | $5.42 | 11,886 | $64K | 50.0% |
| Total | $5.42 avg | 23,772 | $129K | 100% |
| Filing → |
| EDIT | SELL | 2026-06-05 | $2K | — | Filing → |
| EDIT | SELL | 2026-03-04 | $2K | — | Filing → |
| EDIT | SELL | 2025-12-04 | $2K | — | Filing → |